Macrophage activation is a dynamic process that results in diverse functional outcomes ranging from immunoregulation to inflammation. The proinflammatory, or M1, response is a complex, bimodal progression composed of a "prime," classically through IFN-␥, and "trigger," such as LPS. To characterize the physiological response of M1 activation, a systems biology approach was applied to determine the intracellular proteome bioprofiles of IFN-␥-and LPS-treated primary human macrophages. Our goal was to develop intracellular proteomic fingerprints to serve as novel correlates of macrophage priming and/or activation to augment the existing approaches of analyzing secreted cytokines and cell-surface protein expression. The majority of the proteome, ϳ78%, remained stable during activation, representing the core proteome. In contrast, three distinct patterns defined response proteomes: IFN-␥-specific, LPS-specific, or IFN-␥-and LPS-shared or M1-specific. Although steady-state expression levels of proteins involved in energy metabolism and immune response were increased during priming and triggering, changes in protein and fatty acid metabolism, signaling, and transport pathways were most apparent. Unique proteomic fingerprints distinguish among IFN-␥-specific, LPS-specific, or M1-specific activation states and provide a clear molecular, archeological profile to infer recent history of cells, as well as correlates for chronic macrophage activation in health and disease. J. Leukoc. Biol. 
Introduction
Macrophage activation is a dynamic process that can have beneficial or pathogenic effects to human health. A wide spectrum of macrophage activation states, including proinflammatory, regulatory, or wound-healing, is characterized by downstream cytokine secretion profiles [1] . Proinflammatory, or M1, activation aids in host defense against pathogen infections and typically occurs as a biphasic response. For example, microbial LPS, a TLR4 ligand, is sufficient to induce secretion of proinflammatory cytokines, such as TNF, IL-1␤, or IL-6, by macrophages [2] [3] [4] [5] [6] . In contrast, a priming event, classically in response to IFN-␥, is insufficient to stimulate macrophages to release proinflammatory cytokines, although priming sensitizes macrophages, resulting in enhanced secretion of proinflammatory cytokines to subsequent LPS treatment [7] [8] [9] .
Macrophage responses to stimulation result from networks of intracellular signaling molecules working in a regulated and concerted effort to induce transcription factors and prime cellular machinery on a systems level [2, 10, 11] . Although priming of macrophages produces limited change in the profile of secreted proteins, IFN-␥ signals through the STAT pathway(s) to modulate gene expression and the intracellular macrophage proteome [12] , which should differ from the M1 bioprofile produced in macrophages by TLR signaling. Advances in whole proteome analyses, specifically gel-based separation systems, allow unprecedented global views of protein expression. A unique advantage in performing gel-based proteomics is the ability to detect protein variations, which may reflect
Protein fractionation, preparation, and LC-MS/MS analysis
Samples were prepared for analysis by MS as described previously [15, 16] . A one-dimensional SDS-PAGE LC-MS/MS approach was used to accommodate our strategy of maximizing the dynamic range and coverage of the proteome and because this method has demonstrated reproducibility [15, 16] . Briefly, samples were reduced with 10 mM DTT and alkylated with 40 mM iodoacetic acid prior to SDS-PAGE. Gels were fixed and stained with Coomassie blue, prior to slicing into 15 m.w. regions. Each region was subjected to in-gel trypsin digestion for 24 h. Peptides were extracted from the gel slices, lyophilized, and re-dissolved in loading buffer (5% acetonitrile, 0.25% formic acid) for LC-MS/MS analysis. Samples are run on a LCQ DECA XP Plus Proteome X workstation (Thermo Fisher Scientific, Waltham, MA, USA), which produced output as 135 individual RAW spectral files (see "Activated Macrophage Proteomics" at the Tranche Proteome Server: https://proteomecommons.org/. Files: Untreated_Donor1_24h; Untreated_Donor2_24h; Untreated_Donor3_24h; LPS_Donor1_24h; LPS_Donor2_24h; LPS_Donor3_24h; IFN_Donor1_24h; IFN_Donor2_24h; IFN_Donor3_24h).
Data analysis
Peptide IDs were made using SEQUEST through the Bioworks Browser 3.2. Sequential database searches were performed using the National Center for Biotechnology Information RefSeqHuman FASTA database, considering differential carboxymethylated, modified cysteines and oxidized methionines. Peptide score cutoff values were chosen at a cross-correlation of 1.5 for singly charged ions, 2.5 for doubly charged ions, and 3.0 for triply charged ions. Confidence in peptide identifications was increased further by filtering on ⌬CN values Ն0.1, rank of preliminary score values Ն10, and a peptide probability value Ն1e-3. Within each slice, a minimal list of peptides for each protein was determined after duplicates were removed. This list Figure 1 . Profile of LPS-and IFN-␥-induced cytokine secretion by macrophages. Macrophages were treated with media alone (mock, ⅜), 1 g/ml LPS (•), or 1 g/ml IFN-␥ (shaded circles) for 1, 12, 24, and 48 h. Accumulation of (A) TNF, (B) IL-6, (C) IL-1␤, and (D) CXCL10 was determined by ELISA. Data represent mean Ϯ sd of three independent monocyte donors.
was sorted by the total number of peptides in descending order of the number of unique peptides per protein identification. The first peptide array in this list was defined as a cluster and compared pair-wise with every other array in the list by determining whether the N-1 comparison was an equal or a proper subset. If the peptide array were determined to be an equal or proper subset, the array was added to the cluster and removed from the list. The process was repeated until all comparisons were exhausted. For each cluster, the gene with the greatest number of peptide elements was assigned to designate the cluster. If multiple genes within the cluster had the same number of peptides, an arbitrary member was assigned as representative of the cluster. Peptides shared between clusters were identified and removed from further analysis. Peptide area was calculated using the area function in BioWorks 3.2 (Thermo Fisher Scientific) with a scan window of 60. The gene area was calculated as the sum of the areas for each independent analyte for all unique peptides within a cluster. If multiple areas were identified for a given analyte, the largest area was selected and used in the area calculation. An independent analyte is defined as unique mass to charge identified in the SEQUEST search passing the filtering criterion.
Statistical analysis for protein abundance was performed using DAnTE [17] . Spectral counts were log 10 -transformed, and missing data points were estimated by using half of the minimum value across all samples. An ANOVA was applied to identify statistical differences in protein expression levels that correlate with macrophage priming and triggering. Statistical significance was set as P Ͻ 0.05. For purposes of the heat-map, protein abundances were normalized across conditions by z-score and graphed using the OmniViz software package (OmniViz Inc., Tewksbury, MA, USA). Proteins altered in two out of three donors with P Ͻ 0.05 were included for pathway analysis, performed using Database for Annotation, Visualization, and Integrated Discovery [18, 19] , Kyoto Encyclopedia of Genes and Genomes [20 -22] , and BioCarta (BioCarta LLC, San Diego, CA, USA) software. Results of pathway analyses were integrated manually and visualized as a network created in Adobe Illustrator (Adobe Systems Inc., San Jose, CA, USA).
RESULTS

LPS and IFN-␥ induce distinct cytokine expression profiles in macrophages
Activation-induced cytokine/chemokine expression was evaluated over a time course to empirically determine the optimal time-point for whole proteome analysis of chronic priming or activation. Secretion of TNF, IL-1␤, IL-6, or CXCL10 (IP-10) during 48 h of IFN-␥ or LPS stimulation was measured. LPS treatment induced peak secretion of TNF, IL-1␤, and IL-6 within 12-24 h, in contrast to IFN-␥ treatment, which failed to stimulate secretion of any of the three cytokines ( Fig. 1, A-C) . IFN-␥ treatment produced a 50-fold increase in secreted levels of CXCL10 that appeared by 12 h and persisted for 48 h (Fig.  1D) . LPS induced expression of CXCL10, although maximal levels were only tenfold greater than untreated macrophages by 24 h. In general, the secreted cytokine/chemokine response to IFN-␥ or LPS was stable for 24 h, which was the time chosen to develop an intracellular proteomic profile of chronic treatment.
IFN-␥ and LPS perturb intracellular monocytederived macrophage protein expression profiles
Intracellular proteomes in macrophages from three independent donors were assessed using a gel-based, size-fractionation approach and identification by LC-MS/MS. In total, 4474 individual protein identifications, representative of 2207 unique proteins across all treatments and donors, were tallied. The first level of analysis was to determine overall protein distribution by mass among all donors and treatment groups, where physical gel slices are presented as m.w. bins. The total number of proteins based on peptide identifiers within each bin is presented as a reconstructed gel heat-map (heat-gel; Fig. 2A ) Proteins were distributed with variable frequency within bins ranging from Ͻ10 kDa to Ͼ350 kDa but displayed similar profiles across treatments (PϾ0.1).
The next level of analysis was to determine how each treatment affected overall protein distribution within m.w. bins. Data from individual donors were averaged for each treatment to generate consensus estimates of protein distribution. For all treatments, ϳ45% of proteins migrated between 35 kDa and 350 kDa, and ϳ45% migrated in the lower m.w. bins (Ͻ35 kDa). Approximately 10% of the macrophage proteome was comprised of proteins Ͼ350 kDa (bin 1), and almost 10% were in the range Ͻ10 kDa (bin 15). IFN-␥ or LPS treatment compared with each other or to basal levels produced a similar total number of intracellular proteins in any particular bin, indicating that treatments produced no significant shifts in global distribution of proteins based on mass (Fig. 2B) .
To determine the relationship between observed and predicted protein migrations, observed m.w. bins for the 4474 proteins were plotted against their predicted m.w. (Fig. 3) . The median predicted weight for observed proteins (vertical red lines) within individual bins correlated with the expected m.w. ranges of the bins (gray boxes) between 15 and 160 kDa (bins 4 -13). In contrast, there was discordance between observed and predicted protein migrations in the extreme m.w. bins, Ͼ160 kDa and Ͻ15 (bins 1-3 and 14 and 15, respectively). A number of proteins, such as CD36, CD44, or integrin B, identified in the high m.w. region, are targets of additive PTMs, including glycosylation, phosphorylation, and lipidation, at multiple sites, which contribute to significant shifts in gel migration [23] [24] [25] [26] [27] .
Differential protein profiles by treatment
To identify components of IFN-␥-specific, LPS-specific, or M1-specific proteomes, exclusive or shared proteins for each treatment were evaluated. Qualitative analysis examined the distribution of the 2207 unique proteins between treatment groups, and the data were represented by Venn diagrams (Fig. 4) . To increase confidence in treatment-specific identifications across biological replicates, a filter that required proteins be observed in at least two of the three donors was applied, which condensed the list of proteins to 1178. Approximately 78% of proteins, representing the core macrophage proteome, were observed in macrophages independent of treatment (Fig. 4A) , and ϳ22% of proteins defined response-specific proteomes (Fig. 4, A and B) . Response profiles included proteins expressed exclusively during IFN-␥ or LPS treatment (Fig. 4, A  and B) , as well as a subset of proteins that fell below the level of detection with either treatment, representing a selective repression during macrophage activation (Fig. 4, A and B) . Although the IFN-␥ proteome was more similar to the basal condition, overlap between IFN-␥ and LPS proteomes suggested that certain features of priming are necessary events for macrophages to progress to a triggered response.
To develop unique fingerprints for each treatment, proteins found exclusively and with statistical significance (PϽ0.05) in IFN-␥ or LPS treatments relative to basal condition were identified. Three distinct bioprofiles appeared: IFN-␥-responsive (proteins expressed exclusively upon IFN-␥ treatment), LPSresponsive (proteins expressed exclusively upon LPS), and responsive to either activation regime (proteins expressed during IFN-␥ or LPS treatment; Fig. 5) . Validation of the proteomic methodology is evident, where IFN-␥ is detected only in IFN-␥-primed macrophages, most likely reflecting an exogenous recombinant protein that was bound to IFN-␥R1 and/or internalized during culture. IFN-␥ treatment resulted in a statistically significant, increased abundance of several enzymes, including LAP3, CTSB, WARS, and GAA, as well as the outer mitochondrial membrane CYB5B transport protein. In contrast, LPS treatment increased levels of several signaling molecules, including CCR7, IFIT2, ISG15, ISG20, and NAMPT. LPS also increased the expression of transport proteins, TFRC and TRAPPC1. Proteins defining the M1 bioprofile included enzymes, such as ACADM; signaling proteins, including IP-10 (CXCL10), CLIC1, and PCBP2; and transport proteins, such as TAP1 and SLC2A6. Overall, metabolic, signal transduction, and transport pathways were the primary pathways impacted in M1 macrophages.
IFN-␥ priming and activation network analysis
To define the functional context of the bioprofiles of IFN-␥ priming and LPS activation, significantly altered proteins from any treatment group were organized into consensus pathways and interconnected into networks (Fig. 6) . IFN-␥-specific proteins contributed primarily to protein metabolism, immune response, and protein transport. In contrast, LPS produced proinflammatory cytokines and increased levels of ACSL4, which can result in fatty acid metabolism promoting inflammatory lipids, such as PGs, LTs, lipoxins, and PAF [28] .
In addition to IFN-␥-or LPS-specific response factors, several pathways were similarly impacted by either treatment. Specifically, immune response and energy metabolism pathways were modulated the greatest by IFN-␥ priming or LPS activation. IFN-␥ and LPS triggered the production of PCBP1 and PCBP2, two RNA-binding proteins that are known to interact directly with mRNA and viral RNA to control translation [29, 30] , and IDO1, an IFN-induced marker of inflammation that depletes L-tryptophan to prevent the growth of intracellular pathogens or tumor cells [31] . IFN-␥ or LPS similarly decreased the expression of multiple proteins, including MMP9, ABCD1, and thrombospondin receptor (CD36).
DISCUSSION
This study establishes a paradigm for categorizing macrophage activation based on a panel of intracellular biomarkers. Although cellular activation states are traditionally determined by cytokine expression profiles [1, 2] , the diversity of cytokines produced by primed macrophages is limited and nonspecific to macrophages. A global proteome bioprofile for primed as well as triggered macrophages identifies characteristic features that define specific macrophage activation states. Intracellular bioprofiling represents a robust extension to secreted cytokine measurements and a cellsurface marker phenotype, enhancing our understanding and characterization of the M1-activated response proteome.
Macrophage activation is a dynamic and complex process capable of producing a broad spectrum of functional outcomes [1] . The core proteome, which represented ϳ80% of the proteins, remained relatively stable, independent of stimulation, indicating that only modest changes in the proteome can have substantial effects on the functional activity of the cell. In contrast, three distinct bioprofiles characterized unique chronic activation states of macrophages. The response proteome presents a reproducible fingerprint that distinguishes activated from basal macrophages and furthermore, between different chronic stages of classical activation.
Similarities in proteome bioprofiles between IFN-␥ and LPS stimulation, specifically the immune response and metabolism pathways, reinforce the concept that priming and activation are not discrete functional pathways but rather, phases within a progression continuum, resulting in full activation [1] . Substantial overlap between primed and basal macrophage proteomes suggests that temporal structure underlies the activation process and that certain features may be necessary during the course of priming for macrophages to become activated. One key mechanism of shared responses to IFN-␥ and LPS is secretion of type I IFNs. The cellular autocrine response to LPS-induced type I IFNs, IFN-␣ and/or IFN-␤, may induce signaling that mimics IFN-␥ priming to facilitate early events that are required for TLR4-mediated macrophage activation. In addition to regulation of gene and protein expression, subsequent post-translational modifications can extend functional diversity of the proteome [32] .
Ex vivo differentiated human macrophages provide a model for studies of basic macrophage function. Although in vivo tissue-specific macrophages represent a complex population of specialized phenotypes with diverse functions that may not be modeled ideally by ex vivo macrophages [33] [34] [35] , in-depth, unsupervised discovery approaches are difficult to apply when sample size and anatomical location are limiting. An alternative approach presented in this study is development of an empirical biological model that can be used to generate novel hypotheses, which are tested subsequently with supervised, reductionist methods that are compatible with tissue-derived macrophages.
Although receptor engagement by IFN-␥ or LPS stimulates PTMs, specifically phosphorylation, to induce transcription and translation, changes in global protein expression levels reflect upstream signaling events. The extreme m.w. regions of the gels (Ͼ350 and Ͻ15 kDa) produced the greatest protein identifications, which is likely the consequence of multiple processes of PTMs. Although individual modifications on a particular protein may correspond to a specific state, such as priming or triggering, this study is an initial screen of global protein abundance in primary human macrophages. Although several proteins were observed outside of their predicted m.w. regions, the approach used in this study has advantages for identifying targets for focused analysis of novel sites of PTMs.
Metabolic, signal transduction, and transport pathways were impacted by IFN-␥ and LPS. LPS and IFN-␥ decreased the intracellular expression of MMP9, probably by inducing activation through cleavage and secretion of MMP9, which has been observed during activation of macrophages [36, 37] . Increased levels of the cysteine protease, CTSB, were observed during IFN-␥ or LPS stimulation. MMP9 and CTSB are regulated by the NF-B/p38 signaling pathway [37] [38] [39] , contributing to an inflammatory response. As expected, several proteins involved with the immune response were increased, notably, RNA-binding proteins, including PCBP1 and PCBP2, and the tyrosine metabolic enzyme, IDO1, emphasizing the important role of pathogen recognition and clearance upon IFN-␥ and LPS stimulation. A consensus core proteome defines macrophages independent of activation state, and inducible proteomes of IFN-␥-primed versus LPS-triggered macrophages possess unique components that define an activation-specific fingerprint. Exclusive expression of several proteins (LAP3, CTSB, WARS, FAM26F, and CYB5B) provides a positive bioprofile of IFN-␥ priming that distinguishes primed macrophages from basal (resting) or LPS-activated macrophages. Similar to IFN-␥ priming, LPS induced a divergent signature proteome (ISG15, NAMPT, IFIT2, CCR7, and TFRC), which was also unique from basal macrophages. Finally, the shared proteome of IFN-␥-primed and LPS-triggered macrophages distinguishes M1 macrophages from basal macrophages and might reflect complex mechanisms of regulation of STAT or TLR signaling during macrophage activation [40] . Other activation or inhibitory stimuli, for example, triggering through TLRs other than TLR4 or by different pathogens, may produce unique proteomic fingerprints that can be differentiated from basal, IFN-␥, and LPS [2] .
IFN-␥ and TLR signaling are connected intimately during microbial infections, a connection highlighted by cytokine secretion during sequential stimulations [41] . In addition to immune response, other pathways, including adhesion/receptors, tissue remodeling, transporters, and metabolic enzymes, are altered in macrophages by LPS stimulation [42] . Several factors, including CD44 [43, 44] , MMPs [45] , serine proteinase inhibitors [46, 47] , and IDO1 [48] , within these pathways were also identified in our analysis, consistent with previous observations of macrophage response to LPS and infection. An extended, in-depth analysis of macrophage proteomics may yield comprehensive bioprofiles that identify multiple activation states and provide a molecular archeological approach to infer the recent history of a cell through its proteomic fingerprint. 
